Skip to main content
Vetnostrum Animal Health Co., Ltd. logo

Vetnostrum Animal Health Co., Ltd. — Investor Relations & Filings

Ticker · 6936 ISIN · TW0006936008 TW Manufacturing
Open in API
Filings indexed 28 across all filing types
Latest filing 2026-05-14 Governance Information
Country TW Taiwan
Listing TW 6936

About Vetnostrum Animal Health Co., Ltd.

https://www.vetnostrum.com/

Vetnostrum Animal Health Co., Ltd. is a specialist in the animal health sector, focusing on the research, production, and distribution of veterinary pharmaceuticals and functional feed additives. As a subsidiary of the Yung Shin Group, the company leverages pharmaceutical-grade expertise to provide high-quality chemical drugs, non-drug additives, vaccines, and companion animal healthcare products. Its portfolio serves the swine, poultry, ruminant, aquaculture, and pet industries. Vetnostrum operates under rigorous quality standards, including GMP and FAMI-QS certifications, and holds over 180 domestic licenses alongside numerous export permits for international markets in Asia and the Americas. Committed to 'green farming' principles, the company integrates technical support services with its product offerings to enhance animal welfare and ensure the safety of the food supply chain.

Recent filings

Filing Released Lang Actions
公司治理組織架構
Governance Information Classification · 85% confidence The document is from the Taiwan Market Observation Post System (“公開資訊觀測站”) and contains a detailed table of the company’s board composition, independent directors, audit and remuneration committees, legal counsel, and shareholder liaison arrangements. It is not an earnings release, AGM minutes, or financial statements, but a summary of governance structure and internal board rules. This matches the definition of a Governance Information filing (CGR).
2026-05-14 Chinese
115年第1季財務報告書 — 202601_6936_AI2.pdf
Interim / Quarterly Report Classification · 91% confidence The document is the financial report and independent auditor’s review report for Yonghong International Biotech Co., Ltd. for the first quarter of years 115 and 114 (interim period), including balance sheet, income statement, cash flow statement, detailed footnotes on accounting policies and financial note disclosures. It contains full interim financial statements and notes in accordance with IFRS (IAS 34) "Interim Financial Reporting". This aligns exactly with an Interim/Quarterly Report, not merely an earnings release or announcement. Therefore, the correct classification is IR. Q1 2026
2026-05-12 Chinese
115年第1季權益變動表
Interim / Quarterly Report Classification · 90% confidence The document presents actual financial statement data (a statement of changes in equity) for the company’s Q1 period (“民國115年第1季”), including beginning and ending balances, net income, and other comprehensive income. It is part of an interim (quarterly) financial report rather than a simple announcement of publication. Therefore, it should be classified as an Interim/Quarterly Report (IR). Q1 2026
2026-05-11 Chinese
115年第1季現金流量表
Regulatory Filings Classification · 10% confidence The text is a generic access error message with no financial or corporate filing content. It does not match any specific category, so it defaults to the fallback “Regulatory Filings (RNS).”
2026-05-11 Chinese
115年第1季綜合損益表
Interim / Quarterly Report Classification · 85% confidence The document is a standalone individual comprehensive income statement (“個別綜合損益表”) showing detailed quarterly financial results for the first quarter of ROC year 115 (Jan 1–Mar 31) with actual amounts and percentages. It is not merely a notice or link to a report but contains substantive financial data for a period shorter than a full fiscal year, matching the definition of an Interim/Quarterly Report. Q1 2026
2026-05-11 Chinese
115年第1季資產負債表
Interim / Quarterly Report Classification · 95% confidence The document is the standalone individual balance sheet (“個別資產負債表”) showing actual financial line items for the first quarter (dates 115/03/31, 114/12/31, 114/03/31). It provides substantive quarterly financial data rather than simply announcing or linking to a report, indicating it is part of an Interim/Quarterly Report. Q1 2026
2026-05-11 Chinese

Browse filings by year

1 year

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.